A number of structurally diverse compounds cause peroxisome and endoplasmic reticulum proliferation in rodent liver. Accompanying this hypertrophy are changes in protein concentrations and enzymatic activities including: the microsomal fatty acid omega-hydroxylase; catalase; the peroxisomal fatty acid beta-oxidation system; the fatty acid binding protein; glutathione peroxidase; and glutathione transferase. Chemicals that induce these organelles are classified as peroxisome proliferators and include clofibrate, a hypolipidemic agent, and diethylhexyl phthalate (DEHP), a common additive of plastics which gives it flexibility. The study of the health hazards of peroxisome proliferators is important for, besides the liver hypertrophy and enzyme changes, they produce hepatocellular carcinomas. There are marked differences in the response of animal species to peroxisome proliferators with rodents the most responsive. It has been difficult to ascertain whether humans also respond to peroxisome proliferators. Since peroxisome proliferators are comprised of structurally divergent compounds, it has been difficult to account for their common induction properties. The concept of a common receptor protein or common endogenous product that may act as the immediate inducer has been proposed. Since phthalate esters may readily migrate from the plastic materials and contaminate the samples that they are in contact with, it is important to understand their biological effects, as plasticizers are used in food containers, health care products, toys, and household goods. In this grant proposal, enzymatic reactions in rat liver that are altered by DEHP-treatment will be studied. The effect of the fatty acid binding protein on enzymatic reactions will be investigated as this protein is increased by DEHP-treatment. The identity of the protein that binds DEHP will be studied for this receptor may account for the different responses in animal species. DEHP-treatment inhibits two important liver enzymes, the glutathione peroxidase and transferase, that metabolize hydrogen peroxide and reactive chemical compounds and their inhibition may account for the hepatotoxicity. The inhibitory effects of DEHP on these enzymes will be studied. Changes in fatty acid composition of liver microsomes have been detected after DEHP administration and the fatty acid composition of other organelles will be determined. The induction of the cytochrome P-450 that omega-hydrolates fatty acids is unique to peroxisome proliferators and the P-450s that catalyze various omega-hydroxylation reactions will be characterized.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES003771-08
Application #
3251445
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1986-05-01
Project End
1993-07-31
Budget Start
1992-05-01
Budget End
1993-07-31
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Washington State University
Department
Type
Schools of Pharmacy
DUNS #
041485301
City
Pullman
State
WA
Country
United States
Zip Code
99164
Zangar, R C; Kimzey, A L; Okita, J R et al. (2002) Cytochrome P450 3A conjugation to ubiquitin in a process distinct from classical ubiquitination pathway. Mol Pharmacol 61:892-904
Okita, R T; Okita, J R (2001) Cytochrome P450 4A fatty acid omega hydroxylases. Curr Drug Metab 2:265-81
Zangar, R C; Okita, J R; Kim, H et al. (1999) Effect of calcium channel antagonists nifedipine and nicardipine on rat cytochrome P-450 2B and 3A forms. J Pharmacol Exp Ther 290:1436-41
Okita, J R; Johnson, S B; Castle, P J et al. (1997) Improved separation and immunodetection of rat cytochrome P450 4A forms in liver and kidney. Drug Metab Dispos 25:1008-12
Okita, R T; Okita, J R (1996) Prostaglandin-metabolizing enzymes during pregnancy: characterization of NAD(+)-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-dependent prostaglandin omega-hydroxylase. Crit Rev Biochem Mol Biol 31:101-26
Castle, P J; Merdink, J L; Okita, J R et al. (1995) Human liver lauric acid hydroxylase activities. Drug Metab Dispos 23:1037-43
Austin, E W; Okita, J R; Okita, R T et al. (1995) Modification of lipoperoxidative effects of dichloroacetate and trichloroacetate is associated with peroxisome proliferation. Toxicology 97:59-69
Okita, J R; Castle, P J; Okita, R T (1993) Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl)phthalate. J Biochem Toxicol 8:135-44
Okita, R T; Okita, J R (1992) Effects of diethyl phthalate and other plasticizers on laurate hydroxylation in rat liver microsomes. Pharm Res 9:1648-53
Okita, R T; Clark, J E; Okita, J R et al. (1991) Omega- and (omega-1)-hydroxylation of eicosanoids and fatty acids by high-performance liquid chromatography. Methods Enzymol 206:432-41

Showing the most recent 10 out of 12 publications